Tag: cancer product
Immutep gets green light for large-scale cancer product manufacturing for clinical trials
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.
Featured Article
Expressions of interest sought for Wax Converters Textiles
Salea Advisory, on behalf of Administrator Sule Arnautovic, is inviting expressions of interest for the sale or assignment of Wax Converters Textiles Pty Limited, a well-established manufacturing business located in Rutherford, NSW.
